The efficacy of photodynamic therapy for basal cell carcinoma with intralesional injection of radachlorine

The results of evaluation of the efficiency of photodynamic therapy with photosensitizer radachlorine for basal cell carcinoma are represented. The study included patients with primary and recurrent cancer, solitary and multiple foci of different histological subtypes. All tumors corresponded stages...

Full description

Saved in:
Bibliographic Details
Main Author: T. E. Sukhova
Format: Article
Language:Russian
Published: Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association" 2015-09-01
Series:Biomedical Photonics
Subjects:
Online Access:https://www.pdt-journal.com/jour/article/view/75
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850025272782356480
author T. E. Sukhova
author_facet T. E. Sukhova
author_sort T. E. Sukhova
collection DOAJ
description The results of evaluation of the efficiency of photodynamic therapy with photosensitizer radachlorine for basal cell carcinoma are represented. The study included patients with primary and recurrent cancer, solitary and multiple foci of different histological subtypes. All tumors corresponded stages T1-2N0M0. The radachlorine solution was injected into pathological focus at dose of 1.75-3.50 mg/ cm2 of tumor 15 min before the onset of irradiation (wavelength of 662 nm, light dose of 300 J/cm2). The evaluation of efficiency by means of short-term and long-term outcomes was performed on the basis of clinical and cytological data. According to shortterm outcomes evaluation, the total tumor regression was in 43 (95,5%) patients for 47 (95,9%) tumors. The partial regression was achieved in 2 (4,5%) patients, who subsequently had one repeated course of photodynamic therapy with short-term outcome as total tumor regression. All patients with multiple, superficial and nodal forms of basal cell carcinoma had total tumor regression in 100% of cases, with ulcerated form – in 94,4%, with morphea-like form – in 83,3%. During follow-up in subjects, 44 (97,7%) patients had 5-year recurrence-free period. The relapse of tumor was detected in 1 (2,3%) patient after PDT for primary cancer of nasal ala stage Т2N0M0 of solid and adenoid histological subtype. Thus, photodynamic therapy with intralesional injection of radachlorine showed high efficiency for treating all existent clinical forms and histological subtypes of basal cell carcinoma.
format Article
id doaj-art-2c4ca340ff3f4864bc929ef9511edf1a
institution DOAJ
issn 2413-9432
language Russian
publishDate 2015-09-01
publisher Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"
record_format Article
series Biomedical Photonics
spelling doaj-art-2c4ca340ff3f4864bc929ef9511edf1a2025-08-20T03:00:54ZrusNon-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"Biomedical Photonics2413-94322015-09-0143242810.24931/2413-9432-2015-4-3-24-2873The efficacy of photodynamic therapy for basal cell carcinoma with intralesional injection of radachlorineT. E. Sukhova0The State Budgetary Healthcare Institution of Moscow Region «M.F. Vladimirskiy Moscow regional research clinical institute», Moscow, RussiaThe results of evaluation of the efficiency of photodynamic therapy with photosensitizer radachlorine for basal cell carcinoma are represented. The study included patients with primary and recurrent cancer, solitary and multiple foci of different histological subtypes. All tumors corresponded stages T1-2N0M0. The radachlorine solution was injected into pathological focus at dose of 1.75-3.50 mg/ cm2 of tumor 15 min before the onset of irradiation (wavelength of 662 nm, light dose of 300 J/cm2). The evaluation of efficiency by means of short-term and long-term outcomes was performed on the basis of clinical and cytological data. According to shortterm outcomes evaluation, the total tumor regression was in 43 (95,5%) patients for 47 (95,9%) tumors. The partial regression was achieved in 2 (4,5%) patients, who subsequently had one repeated course of photodynamic therapy with short-term outcome as total tumor regression. All patients with multiple, superficial and nodal forms of basal cell carcinoma had total tumor regression in 100% of cases, with ulcerated form – in 94,4%, with morphea-like form – in 83,3%. During follow-up in subjects, 44 (97,7%) patients had 5-year recurrence-free period. The relapse of tumor was detected in 1 (2,3%) patient after PDT for primary cancer of nasal ala stage Т2N0M0 of solid and adenoid histological subtype. Thus, photodynamic therapy with intralesional injection of radachlorine showed high efficiency for treating all existent clinical forms and histological subtypes of basal cell carcinoma.https://www.pdt-journal.com/jour/article/view/75basal cell carcinomaphotodynamic therapylocal use of photosensitizer
spellingShingle T. E. Sukhova
The efficacy of photodynamic therapy for basal cell carcinoma with intralesional injection of radachlorine
Biomedical Photonics
basal cell carcinoma
photodynamic therapy
local use of photosensitizer
title The efficacy of photodynamic therapy for basal cell carcinoma with intralesional injection of radachlorine
title_full The efficacy of photodynamic therapy for basal cell carcinoma with intralesional injection of radachlorine
title_fullStr The efficacy of photodynamic therapy for basal cell carcinoma with intralesional injection of radachlorine
title_full_unstemmed The efficacy of photodynamic therapy for basal cell carcinoma with intralesional injection of radachlorine
title_short The efficacy of photodynamic therapy for basal cell carcinoma with intralesional injection of radachlorine
title_sort efficacy of photodynamic therapy for basal cell carcinoma with intralesional injection of radachlorine
topic basal cell carcinoma
photodynamic therapy
local use of photosensitizer
url https://www.pdt-journal.com/jour/article/view/75
work_keys_str_mv AT tesukhova theefficacyofphotodynamictherapyforbasalcellcarcinomawithintralesionalinjectionofradachlorine
AT tesukhova efficacyofphotodynamictherapyforbasalcellcarcinomawithintralesionalinjectionofradachlorine